The Neural Wiring That Turns Psychological Stress Into Eczema Flares

AAAS / Science

Anyone with eczema knows the pattern. A stressful week at work, a family crisis, a stretch of poor sleep, and then the skin erupts. Dermatologists have observed this connection for decades, and patients report it constantly. But knowing that stress worsens eczema is different from understanding how. The mechanism linking a mental state to an immune response in the skin has remained frustratingly opaque.

A study published March 19 in Science now traces that link with molecular precision.

From patient data to a specific neuron type

Jiahe Tian and colleagues began with clinical data from 51 patients with atopic dermatitis, the medical term for eczema. They found that patients reporting higher psychological stress levels also had more eosinophils accumulating in their skin. Eosinophils are immune cells that release inflammatory proteins and cytokines, and their abundance correlates with the severity of dermatitis flares.

The correlation was clear, but correlation is not mechanism. To find the mechanism, the team turned to mouse models. They identified a subset of neurons in the sympathetic nervous system, the branch responsible for the body's fight-or-flight response, that preferentially send their projections to hairy skin. These neurons are marked by their expression of prodynorphin (Pdyn), a precursor for endogenous opioid peptides.

Switching the pathway on and off

The researchers used two powerful techniques to test whether these Pdyn-positive neurons were truly responsible for stress-induced skin inflammation. Genetic ablation allowed them to selectively destroy these specific neurons while leaving the rest of the nervous system intact. Optogenetic activation let them switch the neurons on with light, triggering their activity without any actual stressor.

The results were decisive in both directions. When the Pdyn-positive sympathetic neurons were removed, stress-induced inflammation dropped substantially. When they were artificially activated, inflammation increased, even in the absence of psychological stress. The neurons were not just correlated with the flares. They were driving them.

The CCL11-CCR3 recruiting signal

The next question was how these neurons communicate with immune cells. The team found that when Pdyn-positive neurons fire, they trigger the release of CCL11, a chemokine that acts as a homing signal for eosinophils. The eosinophils follow this signal into the skin via their CCR3 receptor. Once there, the neurons activate the eosinophils through a second pathway involving the beta-2 adrenergic receptor, the same receptor targeted by drugs like albuterol used in asthma treatment.

This two-step process, recruitment followed by activation, explains why stress-induced flares can be so intense. It is not enough for eosinophils to arrive in the skin. They need to be switched on, and the same neural pathway handles both tasks.

A pathway that may extend beyond eczema

Nicolas Gaudenzio and Lillan Basso, writing in an accompanying perspective, noted that the mechanism identified here may not be unique to atopic dermatitis. Psoriasis and inflammatory bowel disease are also stress-sensitive conditions with immune components, and similar neural-immune circuits could be at work. The researchers themselves have not yet tested whether Pdyn-positive neurons influence inflammation in other organs or other disease contexts, but the shared biology makes it a reasonable hypothesis.

What this means for treatment, cautiously

The study's authors suggest that managing psychological stress alongside conventional therapies like topical steroids and biologics may represent an underutilized strategy for improving eczema outcomes. That is a measured claim, and an important distinction from saying that stress management can replace medical treatment.

There are also pharmacological angles worth exploring. The beta-2 adrenergic receptor and the CCL11-CCR3 axis are both druggable targets with existing compounds available. Whether blocking these pathways in the skin could reduce stress-driven flares without unacceptable side effects is a question for future clinical work.

The study has meaningful limitations. The human component involved 51 patients, a modest sample size. The mechanistic work was done in mice, and the translation from mouse skin immunology to human skin immunology is not always straightforward. Eczema is also a heterogeneous disease; what drives flares in one patient may differ from another. Whether Pdyn-positive neurons play an equally important role across all subtypes of atopic dermatitis remains to be established.

Still, for a condition that affects roughly 10% of the global population and whose stress connection has been observed but never mechanistically explained, the identification of a specific neural circuit, a specific immune cell type, and a specific molecular signaling chain represents a substantive advance.